<SEC-DOCUMENT>0001104659-25-048520.txt : 20250514
<SEC-HEADER>0001104659-25-048520.hdr.sgml : 20250514
<ACCEPTANCE-DATETIME>20250514161154
ACCESSION NUMBER:		0001104659-25-048520
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250514
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250514
DATE AS OF CHANGE:		20250514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cytosorbents Corp
		CENTRAL INDEX KEY:			0001175151
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				980373793
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36792
		FILM NUMBER:		25945615

	BUSINESS ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		973-329-8885

	MAIL ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MedaSorb Technologies CORP
		DATE OF NAME CHANGE:	20060807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILDER ENTERPRISES INC
		DATE OF NAME CHANGE:	20020611
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2515144d1_8k.htm
<DESCRIPTION>FROM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ctso="http://cytosorbents.com/20250514">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_ctso_cytosorbents.com_20250514 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250514_20250514 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001175151 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000004" name="dei:EntityCentralIndexKey">0001175151</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ctso-20250514.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-14</xbrli:startDate>
        <xbrli:endDate>2025-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_904_edei--DocumentType_c20250514__20250514_z0QlWnttgP56"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase">Pursuant
to Section 13 or 15(</span>d<span style="text-transform: uppercase">)<br/>
of the Securities Exchange Act of 1934</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of Earliest Event Reported):
<span><span id="xdx_90A_edei--DocumentPeriodEndDate_c20250514__20250514_zUQzXAjrlVMc"><ix:nonNumeric contextRef="AsOf2025-05-14" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 14, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_909_edei--EntityRegistrantName_c20250514__20250514_zdYLM5cdzIfc"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000011" name="dei:EntityRegistrantName">CYTOSORBENTS CORPORATION</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20250514__20250514_zyvMGjFH5Nhb"><ix:nonNumeric contextRef="AsOf2025-05-14" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityFileNumber_c20250514__20250514_z9xZlyVUD5Jf"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000013" name="dei:EntityFileNumber">001-36792</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20250514__20250514_zbANU8dZCNn5"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000014" name="dei:EntityTaxIdentificationNumber">98-0373793</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of<br/>
incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer Identification No.)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 50%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_901_edei--EntityAddressAddressLine1_c20250514__20250514_zh7k0iZVtML1"><b><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000015" name="dei:EntityAddressAddressLine1">305
        College Road East</ix:nonNumeric></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressCityOrTown_c20250514__20250514_z076lMDsyJmg"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000016" name="dei:EntityAddressCityOrTown">Princeton</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20250514__20250514_zKnwYuhmPV3k"><ix:nonNumeric contextRef="AsOf2025-05-14" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">New Jersey</ix:nonNumeric></span></b></p></td>
    <td style="vertical-align: bottom; text-align: center; font-size: 10pt; width: 50%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20250514__20250514_zelR24pziGIg"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000018" name="dei:EntityAddressPostalZipCode">08540</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_901_edei--CityAreaCode_c20250514__20250514_zucih923oEEe"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000019" name="dei:CityAreaCode">732</ix:nonNumeric></span>) <span id="xdx_904_edei--LocalPhoneNumber_c20250514__20250514_zq8h0vPbB9x2"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000020" name="dei:LocalPhoneNumber">329-8885</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 100%; font-size: 10pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>
</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">(Former name or former address, if changed since last report.)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_900_edei--WrittenCommunications_c20250514__20250514_zRA2Q7FEu0oe"><ix:nonNumeric contextRef="AsOf2025-05-14" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_901_edei--SolicitingMaterial_c20250514__20250514_zswYmbmGSjK4"><ix:nonNumeric contextRef="AsOf2025-05-14" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20250514__20250514_zfd8WWRLFLM8"><ix:nonNumeric contextRef="AsOf2025-05-14" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20250514__20250514_zVITD7LA7QZ2"><ix:nonNumeric contextRef="AsOf2025-05-14" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border: black 1pt solid; width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Name of each exchange on which <br/>
registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center"><span id="xdx_90A_edei--Security12bTitle_c20250514__20250514_zjxYhviskcA7" style="font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000025" name="dei:Security12bTitle">Common Stock, $0.001 par value</ix:nonNumeric></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20250514__20250514_zxGtFrNPcVj5"><ix:nonNumeric contextRef="AsOf2025-05-14" id="Fact000026" name="dei:TradingSymbol">CTSO</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center"><span style="font-size: 10pt">The <span id="xdx_90A_edei--SecurityExchangeName_c20250514__20250514_zaoWKwhD1Urf"><ix:nonNumeric contextRef="AsOf2025-05-14" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC (Nasdaq Capital Market)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging Growth Company <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20250514__20250514_zlMjfjdbSFba"><ix:nonNumeric contextRef="AsOf2025-05-14" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; font-size: 10pt; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 2.02</b></span></td>
    <td style="font-size: 10pt; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results of Operation and Financial Condition</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;On May 14, 2025, CytoSorbents
Corporation issued a press release announcing its financial results for the quarter ended March 31, 2025. A copy of the press release
is furnished herewith as Exhibit 99.1.*</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; font-size: 10pt; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="font-size: 10pt; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibits</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Exhibit<br/>
No.</span></b></span></td>
    <td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Description</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2515144d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td><a href="tm2515144d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of the Company, dated May 14, 2025</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded with the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The information in Item 2.02 of this Form 8-K
shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">SIGNATURES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: May 14, 2025</p></td>
    <td colspan="2">CYTOSORBENTS CORPORATION</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 45%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">By:</td>
    <td style="border-bottom: black 1pt solid; text-align: justify">/s/ Dr. Phillip P. Chan</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name: </td>
    <td>Dr. Phillip P. Chan</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title:</td>
    <td>Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZi6axLuzSokWsIkXEbbBTCbaZMol/R/KWxhZxGBiG9773hBiJnFamQYbToizggG3XaI9QYo2M9ozBka03KYRb4sU4z9r6/v2BGQUGAzMbK6WD0FvvxmGVgkwmUk1UAnKaxnPYb0X01TOytanQeqMb0LaCPVPHBr3m15Bw0E+y1L76qiOyM2RTiMdykN+gZKxgR3f9IL46KIpMRKN+IpEz3brgWj492i8JywbbUOcG+r/RBwV6Sos= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2515144d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="tm2515144d1_ex99-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CytoSorbents Reports First Quarter 2025 Financial
Results and Provides Business Update</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRINCETON,
N</FONT><FONT STYLE="font-size: 10pt">.J</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">., May&nbsp;14, 2025 &mdash;&nbsp;<U>CytoSorbents
Corporation</U> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery
using blood purification, today reported financial results for the first quarter ended March&nbsp;31, 2025, and recent business highlights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>First Quarter 2025 Financial Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product revenue was $8.7 million, a decrease
of 3%, and flat on a constant currency basis, compared to $9.0 million in Q1 2024.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #201f1e">Gross margin was 71% compared
to 77%</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">in Q1 2024.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating loss improved by 17% to $3.9 million
compared to $4.7 million in Q1 2024, reflecting a 12% reduction in operating expenses.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss was $1.5 million or $0.02 per share,
compared to net loss of $6.1 million or $0.11 per share in Q1 2024.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #201f1e"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjusted net loss<SUP>(1)</SUP>&nbsp;was $3.7
million or $0.06 per share, compared to an adjusted net loss of $3.7 million or $0.07 per share in Q1 2024.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #201f1e"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjusted EBITDA<SUP>(2)</SUP>&nbsp;loss improved
by 17% to $2.7 million compared to a loss of $3.3 million in Q1 2024.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #201f1e"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total cash, cash equivalents, and restricted
cash of $13.1 million at March&nbsp;31, 2025, compared to $9.8 million as of December&nbsp;31, 2024, reflecting proceeds from the Rights
Offering of $6.8 million, net of fees, and net cash used in the quarter of approximately $3.7 million which includes disbursements unique
to Q1 of approximately $0.9 million.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #201f1e"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On April&nbsp;21, the Company received $1.7 million
in cash proceeds from the sale of its 2023 and amended 2022 Net Operating Loss and R&amp;D tax credits from the Technology Business Tax
Certificate Transfer Program, sponsored by the New Jersey Economic Development Authority (NJEDA).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.5in">(1)</TD><TD STYLE="font-size: 10pt; text-align: justify">Adjusted net income is a non-GAAP financial measure. For a reconciliation of Adjusted net income to the
most comparable GAAP measure, see the reconciliation included in the financial tables. All non-GAAP adjustments are presented pre-tax.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Adjusted EBITDA is a non-GAAP
financial measure. For a reconciliation of Adjusted EBITDA to the most comparable measure, see the reconciliation included in the financial
tables.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;Strong revenue
growth in our distributor and other direct sales territories across the E.U. helped to substantially offset a temporary disruption in
direct sales in Germany during the quarter. This was primarily due to our proactive reorganization and strategic realignment of our German
commercial team and sales approach that is intended to renew sales growth in the country through deeper customer engagement, more effective
market development, and improved sales representative productivity,&rdquo; stated Dr.</FONT>&nbsp;Phillip Chan, Chief Executive Officer
of CytoSorbents. &ldquo;We are making steady progress with this important initiative and are confident it will lead to stronger execution
and improved performance in Germany and our financial results overall this year, as we continue to advance our core business toward near
breakeven.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Dr.&nbsp;Chan continued,
&ldquo;Meanwhile, our message - <B><I>Treating</I></B></FONT><B><I> the right patient, at the right time, with the right dose of</I> CytoSorb&reg;
</B>- continues to resonate strongly with clinicians. The approach is much like using antibiotics: start early, treat aggressively, and
complete the full course. When used this way, CytoSorb has been shown to disrupt the deadly cycle of inflammation, stabilize patients
in shock, protect organ function, and ultimately improve clinical outcomes. Recent data confirm that early and aggressive use of CytoSorb
leads to statistically significant improvements in survival and other key clinical indicators. We are now using this evidence to train
our users and are confident our guidance will continue to drive broader adoption and more effective usage of this critical therapy.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Business Highlights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Completed Shareholder Rights Offering and raised total proceeds of $6.8 million,
net of fees, from the offering, and the exercise of the Series&nbsp;A Right Warrant. The raise also allowed for the release of $5.0 million
of restricted cash on the Company&rsquo;s balance sheet, and combined, provided increased liquidity of $11.8 million.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expanded our global footprint with the opening of our new regional sales
subsidiary in Dubai, United Arab Emirates, providing a gateway into the Middle East and Africa.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Appointed Thomas Shannon as Vice President of
Marketing for North America to lead the marketing strategy and execution for DrugSorb&trade;-ATR in the U.S. and Canada.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.25in"></TD><TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Appointed Melanie Grossman, CPA as Vice President
and Corporate Controller.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company remains deeply committed to bringing DrugSorb&trade;-ATR, an Investigational FDA Breakthrough Designated Device, to the large
and important North American market, as a critical solution to address the serious, unmet need of reducing life-threatening bleeding in
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">patients on Brilinta&reg; undergoing coronary artery bypass grafting (CABG)
surgery. Awareness of DrugSorb-ATR&rsquo;s potential to lessen bleeding severity in this high-risk population continues to grow. Compelling
new real-world data from Europe on our technology, </FONT>being presented and published throughout 2025, further reinforces the device&rsquo;s
potential clinical impact to meaningfully reduce perioperative bleeding severity and provide surgeons with an important therapy to address
this ongoing challenge in cardiac surgery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April&nbsp;25, 2025, the U.S. Food and Drug
Administration (FDA) issued a denial letter regarding the Company&rsquo;s De Novo Request for DrugSorb-ATR, citing outstanding items that
must be addressed before the device can be authorized for U.S. commercialization. The Company believes these items can be most effectively
and expeditiously resolved through the formal appeal process that enables direct interaction and engagement with FDA senior leadership
and our external experts. Given the expedited timelines associated with the appeal process, we believe that a final regulatory decision
can be achieved in 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr.&nbsp;Efthymios N. Deliargyris, Chief Medical
Officer of CytoSorbents stated, &ldquo;We remain confident in the strength of our DrugSorb-ATR De Novo Request and believe the remaining
issues can be successfully addressed. We are committed to working collaboratively with the FDA to secure marketing authorization for this
FDA Breakthrough Designated Device, which has the potential to address a significant and routine challenge faced by cardiac surgery centers.
We believe the formal appeals process offers the most efficient path forward to resolve the remaining issues and bring this important
technology to patients in the U.S. Meanwhile real-world adoption continues to grow with an increasing number of heart centers around the
world incorporating our technology as part of their standard care to reduce bleeding complications in patients on blood thinners undergoing
cardiac surgery based on the growing evidence from our international STAR Registry showing that our device is a safe and effective strategy
to address this major clinical need.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Finally, CytoSorbents&rsquo; DrugSorb-ATR application
with Health Canada remains under advanced review. While Health Canada has indicated that application reviews are currently delayed beyond
their target Market Authorization Times (MAT) due to a backlog, Health Canada has confirmed its commitment to issuing a decision at the
earliest opportunity. We remain confident in receiving a final regulatory decision in 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>First Quarter 2025 Earnings Conference Call</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CytoSorbents&rsquo; management will host a live conference call, presentation
webcast, and a question-and-answer session with the following information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Date: </B></FONT> Wednesday, May&nbsp;14,
2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Time:</B></FONT> 4:30 PM ET</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>North American toll-free:</B></FONT>
1-800-836-8184</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>International toll:</B></FONT> 1-646-357-8785</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Live webcast link: </B></FONT><U>https://app.webinar.net/Vbq3lbYwAy5</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is recommended that participants dial in approximately
10 minutes prior to the start of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An archived recording of the conference call will
be available under the Investor Relations section of the Company&rsquo;s website at https://ir.cytosorbents.com/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Non-GAAP Financial Measures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To supplement our condensed consolidated financial
statements, we use the non-GAAP financial measures of EBITDA, which measures earnings before interest, income taxes, depreciation and
amortization, and Adjusted EBITDA which further excludes non-cash stock compensation expense, and gain or loss of foreign exchange translation.
We also use the non-GAAP financial measures of Adjusted Net Income or Loss and Adjusted Net Income or Loss Per Common Share which excludes
non-cash stock compensation expense and gain or loss of foreign exchange translation from Net Loss and Net Loss Per Common Share, respectively.
These non-GAAP measures are not based on any comprehensive set of accounting rules&nbsp;or principles and should not be considered a substitute
for, or superior to, financial measures calculated in accordance with GAAP and may be different from non-GAAP measures used by other companies.
In addition, these non-GAAP measures should be read in conjunction with our financial statements prepared in accordance with GAAP. The
reconciliations of the non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with
GAAP should be carefully evaluated. We use these non-GAAP financial measures for financial and operational decision-making and as a means
to evaluate period-to-period comparisons. We believe that these non-GAAP financial measures provide meaningful supplemental information
regarding our performance and that both management and investors benefit from referring to these non-GAAP financial measures in assessing
our performance and when planning, forecasting, and analyzing future periods. We believe these non-GAAP financial measures are useful
to investors because (1)&nbsp;they allow for greater transparency with respect to key metrics used by management in its financial and
operational decision-making and (2)&nbsp;they are used by investors and the analyst community to help them analyze the performance of
our business, the Company&rsquo;s cash available for operations, and the Company&rsquo;s ability to meet future capital expenditure and
working capital requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About CytoSorbents Corporation (NASDAQ: CTSO)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>CytoSorbents
Corporation</U></FONT>&nbsp;is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery
through blood purification. CytoSorbents&rsquo; proprietary blood purification technologies are based on biocompatible, highly porous
polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Cartridges
filled with these beads can be used with standard blood pumps already in the hospital (e.g. dialysis, continuous renal replacement therapy
or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body,
through our cartridges where toxic substances are removed, and then back into the body. CytoSorbents&rsquo; technologies are used in
a number of broad applications. Specifically, two important applications are 1) the removal of blood thinners during and after cardiothoracic
surgery to reduce the risk of severe bleeding, and 2) the removal of inflammatory agents and toxins in common critical illnesses that
can lead to massive inflammation, organ failure and patient death. The breadth of these critical illnesses includes, for example, sepsis,
burn injury, trauma, lung injury, liver failure, cytokine release syndrome, and pancreatitis as well as the removal of liver toxins that
accumulate in acute liver dysfunction or failure the removal of myoglobin in severe rhabdomyolysis that can otherwise lead to renal failure.
In these diseases, the risk of death can be extremely high, and there are few, if any, effective treatments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">CytoSorbents&rsquo;
lead product,&nbsp;</FONT><U>CytoSorb<SUP>&reg;</SUP></U>, is approved in the&nbsp;European Union&nbsp;and distributed in over 70 countries
worldwide, with more than a quarter million devices used cumulatively to date. CytoSorb was originally launched in the&nbsp;European
Union&nbsp;under CE mark as the first cytokine adsorber. Additional CE mark extensions were granted for bilirubin and myoglobin removal
in clinical conditions such as liver disease and trauma, respectively, and for&nbsp;<U>ticagrelor</U>&nbsp;and&nbsp;<U>rivaroxaban</U>&nbsp;removal
in cardiothoracic surgery procedures. CytoSorb has also received&nbsp;<U>FDA Emergency Use Authorization</U>&nbsp;in&nbsp;the United
States&nbsp;for use in adult critically ill COVID-19 patients with impending or confirmed respiratory failure. CytoSorb is not yet approved
or cleared in&nbsp;the&nbsp;United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S. and Canada, CytoSorbents is developing the DrugSorb&trade;-ATR antithrombotic removal system, an investigational device based
on an equivalent polymer technology to CytoSorb, to reduce the severity of perioperative bleeding in high-risk surgery due to blood thinning
drugs. It has received two&nbsp;</FONT>FDA Breakthrough Device Designations<FONT STYLE="font-family: Times New Roman, Times, Serif">:
one for the removal of&nbsp;</FONT>ticagrelor<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;and another for the removal
of the&nbsp;</FONT>direct oral anticoagulants (DOAC) apixaban and rivaroxaban<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;in
a cardiopulmonary bypass circuit during urgent cardiothoracic procedures. In September&nbsp;2024, the Company submitted a De Novo Request
to the&nbsp;U.S.&nbsp;FDA requesting marketing approval to reduce the severity of perioperative bleeding in CABG patients on the antithrombotic
drug ticagrelor, which was </FONT>accepted for substantive review in October&nbsp;2024<FONT STYLE="font-family: Times New Roman, Times, Serif">.
On April&nbsp;25, 2025, the FDA issued a denial letter regarding the Company&rsquo;s De Novo Request for DrugSorb-ATR, identifying remaining
deficiencies that must be addressed before the De Novo Request can be granted, and the device can be authorized for commercialization
in the U.S. The Company believes these items can be most effectively and expeditiously resolved through the formal appeal process, which
facilitates engagement with FDA senior leadership and our external surgical experts. Given the expedited timelines associated with the
appeal process, the Company believes that a final regulatory decision can be achieved in 2025. In November&nbsp;2024, the Company received
its MDSAP </FONT>certification and submitted its Medical Device License (MDL) application to Health Canada<FONT STYLE="font-family: Times New Roman, Times, Serif">.
CytoSorbents&rsquo; DrugSorb-ATR application with Health Canada remains under advanced review. While Health Canada has indicated that
application reviews are currently delayed beyond their target Market Authorization Times (MAT) due to a backlog, they have reaffirmed
their commitment to issuing a decision at the earliest opportunity. The Company remains confident in receiving a final regulatory decision
in 2025. DrugSorb-ATR is not yet granted or approved in the United States and Canada, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has numerous marketed products and products under development based upon this unique blood purification technology protected
by many issued&nbsp;U.S.&nbsp;and international patents and registered trademarks, and multiple patent applications pending, including
ECOS-300CY&reg;, CytoSorb-XL&trade;, HemoDefend-RBC&trade;, HemoDefend-BGA&trade;, VetResQ&reg;, K+ontrol&trade;, DrugSorb&trade;, ContrastSorb,
and others. For more information, please visit the Company&rsquo;s website at&nbsp;</FONT><U>https://ir.cytosorbents.com/</U> <FONT STYLE="font-family: Times New Roman, Times, Serif">or
follow us on&nbsp;Facebook&nbsp;and&nbsp;X.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This press
release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives,
future targets and outlooks for our business, representations and contentions, and the outcome of our regulatory submissions, and are
not historical facts and typically are identified by use of terms such as &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo;
&ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;predict,&rdquo;
&ldquo;potential,&rdquo; &ldquo;continue&rdquo; and similar words, although some forward-looking statements are expressed differently.
You should be aware that the forward-looking statements in this press release represent management&rsquo;s current judgment and expectations,
but our actual results, events and performance could differ materially from those in the forward-looking statements. Factors which could
cause or contribute to such differences include, but are not limited to, our restructuring of our direct sales team and strategy in Germany,
our ability to resolve deficiencies in the FDA denial letter through a successfully appeal the FDA&rsquo;s decision, and the risks discussed
in our Annual Report on Form&nbsp;10-K, filed with the SEC on March&nbsp;31, 2025, as updated by the risks reported in our Quarterly Reports
on Form&nbsp;10-Q, and in the press releases and other communications to shareholders issued by us from time to time which attempt to
advise interested parties of the risks and factors which may affect our business. We caution you not to place undue reliance upon any
such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise, other than as required under the Federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Please
Click to Follow Us on </U></B></FONT><B><U>Facebook and X</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>U.S.
Company Contact:</B></FONT><BR>
Peter J. Mariani, Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">305 College Road East</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Princeton, NJ 08540</P>

<P STYLE="text-decoration: underline; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">pmariani@cytosorbents.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aman Patel, CFA&nbsp;&amp; Adanna G. Alexander, PhD</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICR Healthcare</P>

<P STYLE="text-decoration: underline; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@cytosorbents.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CYTOSORBENTS CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">March&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2025</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(unaudited)</B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">ASSETS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current Assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">11,587,275</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">3,279,926</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Restricted cash, current</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Grants and accounts receivable, net of allowances of $173,356 and $157,701&nbsp;&nbsp;&nbsp;as of March&nbsp;31, 2025 and December&nbsp;31, 2024, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,670,399</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,319,597</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Inventories</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,018,524</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,732,907</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,136,706</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,270,812</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Total current assets</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">25,412,904</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">21,603,242</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment - net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,722,953</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,002,383</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Restricted cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,522,458</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,483,958</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Right-of-use asset</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11,368,340</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11,511,236</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,755,029</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,770,681</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,781,684</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">47,371,500</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current Liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,325,386</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,339,885</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued expenses and other current liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,936,791</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,031,670</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Lease liability &ndash; current portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">473,889</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">452,688</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Total current liabilities</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">9,736,066</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">9,824,243</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Lease liability, net of current portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12,316,119</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12,443,971</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Long-term debt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,186,715</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,996,350</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">36,238,900</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">36,264,564</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Commitments and Contingencies</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Stockholders&rsquo; equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Preferred Stock, par value $0.001, 5,000,000 shares authorized; no shares issued and outstanding as of March&nbsp;31, 2025 and December&nbsp;31, 2024</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Common Stock, par value $0.001, 100,000,000 shares authorized as of March&nbsp;31, 2025 and December&nbsp;31, 2024; and 62,529,466 and 54,830,146 shares issued and outstanding as of March&nbsp;31, 2025 and December&nbsp;31, 2024, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">62,529</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">54,830</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Additional paid-in capital</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">318,451,572</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">310,808,711</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated other comprehensive income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,515,656</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,252,013</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(305,486,973</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(304,008,618</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">14,542,784</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">11,106,936</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">50,781,684</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">47,371,500</TD><TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to condensed consolidated
financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CYTOSORBENTS CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE LOSS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Three Months Ended March&nbsp;31,</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2025</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">Product revenue</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">8,727,238</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">8,989,520</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cost of goods sold</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,519,641</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,115,910</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Gross profit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,207,597</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,873,610</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development, net of grant income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,662,925</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,246,911</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Selling, general and administrative</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,431,877</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9,283,067</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10,094,802</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">11,529,978</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Loss from operations</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,887,205</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,656,368</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Other income (expense)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(605,134</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,653</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Gain (loss) on foreign currency transactions</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,013,984</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,425,690</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total other income (expense), net</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,408,850</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(1,432,343</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Loss before benefit from income taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,478,355</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,088,711</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Benefit from income taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss attributable to common stockholders</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,478,355</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,088,711</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.11</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Weighted average number of shares of common stock outstanding</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">60,731,929</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">54,434,609</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Comprehensive loss:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss attributable to common stockholders</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,478,355</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,088,711</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Other comprehensive income (loss):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Foreign currency translation adjustment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,736,356</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,223,175</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Comprehensive loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,214,711</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,865,536</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to condensed consolidated
financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CYTOSORBENTS CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES
IN STOCKHOLDERS&rsquo; EQUITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Accumulated</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Additional</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Other</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Common&nbsp;Stock</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Paid-In</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Comprehensive</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Accumulated</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Stockholders&rsquo;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Shares</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Par&nbsp;value</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Capital</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Income (Loss)</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Deficit</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Equity</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 22%">Balance as of December31, 2024</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">54,830,146</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">54,830</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">310,808,711</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">4,252,013</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">(304,008,618</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">11,106,936</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">Stock-based compensation</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">32,321</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">32</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">818,394</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">818,426</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock from exercise of warrants</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">1,417,208</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">1,417</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">1,438,411</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">1,439,828</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock and warrants from Rights Offering, net of fees incurred</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">6,249,791</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">6,250</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;5, 386,056</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">5,392,306</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">Other comprehensive loss, foreign currency translation adjustment</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">(2,736,357</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">(2,736,357</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net loss</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">(1,478,355</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">(1,478,355</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance as of March&nbsp;31,&nbsp;2025</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">62,529,466</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">62,529</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">318,451,572</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">1,515,656</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">(305,486,973</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">14,542,784</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Accumulated</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Additional</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Other</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 8pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Common&nbsp;Stock</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Paid-In</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Comprehensive</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Accumulated</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Stockholders&rsquo;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="font-size: 8pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Shares</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Par&nbsp;value</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Capital</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Income (Loss)</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Deficit</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Equity</TD><TD STYLE="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 22%">Balance as of December31, 2023</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">54,240,265</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">54,240</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">306,187,314</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">529,321</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">(283,289,661</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 10%; text-align: right">23,481,214</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">Stock-based compensation</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">959,465</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">959,465</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left">Issuance of common stock offerings, net of fees incurred</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">53,290</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">54</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">53,185</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">53,239</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 8pt Times New Roman, Times, Serif; text-align: left">Other comprehensive income, foreign currency translation adjustment</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">1,223,175</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right">1,223,175</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net loss</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">(6,088,711</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">(6,088,711</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="font-size: 8pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance as of March&nbsp;31,&nbsp;2024</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">54,293,555</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">54,294</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">307,199,964</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">1,752,496</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">(289,378,372</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right">19,628,382</TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to condensed consolidated
financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CYTOSORBENTS CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(UNAUDITED)</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Three</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Three</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Months Ended</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Months Ended</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">March&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">March&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2025</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from operating activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss attributable to common stockholders</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,478,358</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,088,711</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Amortization of debt discount</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">190,365</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Depreciation and amortization</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">368,503</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">397,286</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Amortization of right-of-use asset</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">36,245</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">45,927</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Bad debt expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,890</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">29,240</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Impairment of patents</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">64,296</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Foreign currency transaction (gains) losses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,013,984</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,425,690</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Debt costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10,713</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Stock-based compensation</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">818,426</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">959,465</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Changes in operating assets and liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Grants and accounts receivable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(79,889</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(848,330</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Inventories</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(198,802</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(429,869</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">257,931</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">886,258</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accounts payable and accrued expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(367,282</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,281,724</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,464,955</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,829,759</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from investing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Purchases of property and equipment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,121</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(45,191</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Patent costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(45,121</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(81,827</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(47,242</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(127,018</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash flows from financing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Repayment of long-term debt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(625,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Proceeds from exercise of common stock warrants</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,439,828</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">53,238</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Proceeds from rights offering, net of fees incurred</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,392,306</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash provided by (used in) financing activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,832,134</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(571,762</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Effect of exchange rates on cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">25,912</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,782</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net change in cash, cash equivalents, and restricted cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,345,849</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,522,757</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash, cash equivalents, and restricted cash at beginning of year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9,763,884</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,615,095</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash, cash equivalents, and restricted cash &ndash; end of period</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">13,109,733</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">10,092,338</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental disclosure of cash flow information</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash paid for interest</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">506,250</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">199,418</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental disclosure of non-cash financing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Fair value of common stock warrants issued in connection with the rights offering</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">555,988</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Offering fees included in accounts payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">252,783</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">March&nbsp;31,</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2025</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">11,587,275</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">8,608,380</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Restricted cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,522,458</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,483,958</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">Total cash, cash equivalents, and restricted cash</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">13,109,733</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">10,092,338</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Reconciliation of GAAP Financial Measures to Non-GAAP Financial
Measures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="6" STYLE="border-bottom: Black thin solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">Quarter
and Year to Date</FONT></TD>
<TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Mar 31,</FONT></TD>
<TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Mar 31,</FONT></TD>
<TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(In thousands, except per share amounts)</FONT></TD>
<TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">2025</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">2024</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt"><B>Net loss</B></FONT></TD>
<TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(1,478</FONT></TD>
<TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(6,089</FONT></TD>
<TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Depreciation and amortization expense</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">369</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">397</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Income tax expense (benefit)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">--</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">--</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">Interest expense
(income)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">605</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">7</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">EBITDA - non GAAP</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(505</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(5,685</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Non cash stock-based compensation
expense</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">818</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">959</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">(Gain)/Loss&nbsp;&nbsp;on
foreign currency translation</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(3,014</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">1,426</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
<TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">Adjusted
EBITDA - non GAAP</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(2,700</FONT></TD>
<TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(3,300</FONT></TD>
<TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt"><B>Net loss</B></FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(1,478</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(6,089</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Non cash stock-based compensation
expense</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">818</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">959</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">(Gain)/Loss&nbsp;&nbsp;on
foreign currency translation</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(3,014</FONT></TD>
<TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">1,426</FONT></TD>
<TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">Adjusted
net income (loss) - non GAAP</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(3,674</FONT></TD>
<TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(3,703</FONT></TD>
<TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt"><B>Weighted
average common shares outstanding basic and diluted</B></FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">60,731,929</FONT></TD>
<TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">54,262,790</FONT></TD>
<TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt"><B>Loss per common share &mdash;
basic and diluted</B></FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(0.02</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(0.11</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Non cash stock-based compensation
expense</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">0.01</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">0.02</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">(Gain)/Loss&nbsp;&nbsp;on
foreign currency translation</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(0.05</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">0.03</FONT></TD>
<TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
<TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Adjusted net income (loss)
per common share - basis and diluted - non GAAP</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(0.06</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">(0.07</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ctso-20250514.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaWPmbOdzZR+eYkxtmBzbdmKDygpte6w6SymzGi2cQIM -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ctso="http://cytosorbents.com/20250514" elementFormDefault="qualified" targetNamespace="http://cytosorbents.com/20250514">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cytosorbents.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20250514_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20250514_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ctso-20250514_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ctso-20250514_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cytosorbents.com/role/Cover" xlink:href="ctso-20250514.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cytosorbents.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2515144d1_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2515144d1_ex99-1img01.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !Z GL# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBBN<
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M>"&T*)M$?PGH/B6X\/,+C5/M)U"6_P!8BL+G6=-NH;:&!+*\L(Y+*9TFE?\
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ME[3V%6FJ4[MIZZI7NOD[KHTU9H]^-2,OWM-^UIV^%--?+J_,FHHHI&@4444
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MG"SG#TI5LOLDZ:C>%UINES:I)_'U9^YW[!'[0/PA_:&_8IU;_@GIXW^)-O\
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MH3I32C97]Z4*KO:Z=FW^Y/\ P3Y_X)_S?L)-\6]WQ6;XGO\ %9O A7_BA(_
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M)M]"URXEC.UER\END\<(&";E[<?,I*/]I7]WA#W=%_J:MO\ LC5WOW$?7/\
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MN=2U:63SY]3O)=H9[RXNO]*F=/+C:?YA&J_+7>?"?X/_ !4^.GCG2/AI\'_
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M0VMO!))EHK:!3MKU#_@F?^Q5XM_;A_:G\#?#VPT'4)_A;X6\0>$_&7QP\3/
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MX56^W1_W?_'HO_DBE^VQ_P!T?]]P_P#R37,J-514$J2BM%'GT_&3?XBYY_\
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M1O\ >%F?Y6JUZ6O'\)/UVC_T$BEX_N _E_1A3^IU/^@J?_@:_P SK_M"K_T
M9?\ ^"?_ +H>.RV?Q<'^JO[1N/XH-+_^5R_YZ50EL/C4/]5JUJW^];:+^'32
ME_S^=>Y83^[_ "_^)I>/0_F/\*\[ZCA?^@_,/_)O_E9M_:\O^A/D_P#X)?\
M\T'SI+IOQZ'^JUG3V_WK;13_ "TU?\]JSIM-_:,7_5Z[IIZ_>AT'_P"4R_YS
M7TUL/J_Z_P"%)Y;>LA_S[ 4O[(H_]#G,O_!D?_F<U_UDJ_\ 0@R3_P )E_\
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M_?H?_$5G_JFNG$.;_P#@_P#^]D=W_$3*_P#T27AG_P"(O07_ +F/R/E\'_\
M!593^[^(WA5OK:?"P_R\##_/:L^7P9_P5G7_ %7Q*\'M];/X6G^7@@?_ *N]
M?K_^Y]4_[]#_ .)I<Q>J_P#?L?X5/^J,/^A_G'E^_P#_ +B;?\17Q'_1%^%/
M_B'9=K^&A^-DO@C_ (*YC_5?$;P2W^]I/PG/\O BUF2^ /\ @L.O^J^)GP_;
MZV/PE/\ +X6+^?Z5^TV$_P">BG_@"?T44[<G]]?^^13_ -4H=>(<Y?\ W,R_
M6D:_\16J_P#1"^$;_P"[&R;]<-H?B!-\/_\ @LTO^J^*'P^;ZZ9\(3_+X4C_
M /5[UGR_#_\ X+4K_JOBG\/6_P![2O@^>WM\*%K]T/-'_/0?]^Q_\32>8O\
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M/8_]_D'\A2;3_??_ +^P_P#Q%3_JE'_HHLY_\*/_ +F<_P#Q&C&_]&Z\&_\
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MA.7XI^//#/@6/QUXB3PEX0;Q UU!_;GB.[B+6&DVIBC<BZ=]K.C+AXV_=LK
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ME%:.:G=*Z:3:UT:NXN5CWZ'AGP)0XOR;PNSOB'BK#<<9M7R/ QS_  =+(:G
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M=\=^ ?A3JLOB3QMXW33Y1)I>B:_JT?BOQSI\=WI[Q,\.HZ9XPMK5)[RPU/\
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ME;C=,=L_U>O1P>"CE& ]G3J3J3M*3JR;<Y-R5VW)6;LDOAMOO=GS'$_'&/\
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)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 14, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 14,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYTOSORBENTS CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001175151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0373793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">305
        College Road East<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">329-8885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CTSO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( 'J!KEI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( 'J!KEK% F"/[@   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%.PS ,AE\%Y=ZZ:2F'J,MEB!-(2$P"<8L2
M;XMHTB@Q:O?VM&'KA. !.,;^\_FSY$X'H8>(SW$(&,EBNIE<[Y/08<..1$$
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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ML6VDYW+W,S\^4-/H!3+*\O]D=[BVT;!(L,VTC(_!0!"+Y/#)WH^). OPZ(4
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M;%!+ 0(4 Q0    ( 'J!KEK% F"/[@   "L"   1              "  <,
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( 'J!KEJ97)PC$ 8  )PG
M   3              "  > !  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ >H&N6G(^%*!/!   ?Q   !@              ("!(0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( 'J!KEJ?H!OPL0(  .(,
M   -              "  :8,  !X;"]S='EL97,N>&UL4$L! A0#%     @
M>H&N6I>*NQS     $P(   L              ( !@@\  %]R96QS+RYR96QS
M4$L! A0#%     @ >H&N6JK$(A8S 0  (@(   \              ( !:Q
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( 'J!KEHD'INBK0   /@!   :
M              "  <L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( 'J!KEIED'F2&0$  ,\#   3              "  ; 2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2515144d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cytosorbents.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ctso-20250514.xsd</File>
    <File>ctso-20250514_lab.xml</File>
    <File>ctso-20250514_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2515144d1_8k.htm">tm2515144d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2515144d1_8k.htm": {
   "nsprefix": "ctso",
   "nsuri": "http://cytosorbents.com/20250514",
   "dts": {
    "schema": {
     "local": [
      "ctso-20250514.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ctso-20250514_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ctso-20250514_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2515144d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://cytosorbents.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2515144d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2515144d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-25-048520-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-048520-xbrl.zip
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MX;C4@-VS!/+MH?*MT-8PYO+<N:<SYOQUKKC++G4'P^."IP@0?!]SI BJ18K
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MP D-,$+)!1W'+#W V)YW[F.F"K!^PW)GQS((B^TM6B+=-6MLNLXLGA"_,3*
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MVT4].H(>UV2".M8(FP?>@P/ [] ^7]XZ?0J&Z939!IY5D&F9A+?1:84O5>+
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MR_<;4Z!>D,TUQ)F3BS!#S"8:3Y1T1,T]ZC($!@,4QGGW'70X@L+%JD&@R3"
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MME.3]3!FD G-4M7ZD&B/8F\%VQ"X@-O@R:UJ39%*#&O"Y\X;.8=0*7V)^M2
MY8DH T/F$E,G.M_F870T-EQL$FO,C!EBD&"Q_DR,] =8*B#&?HXL&D+%VC'
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MP(J[,C('RH/KQ;@0V,PNKI,(K=WI#H^/H1$(X,(30-T7P!:)X9;98SYRTB/
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M'O)EA9;>SR:J>GNC7?SE9#NGDX^'78N=>!S)\O?:B_\SP1T9U?\"4$L#!!0
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M188#6 G#TDMX260IQCWN*%<:-[6B1-*8A38T3V2P%U=U^ECVC;34$9B(5&
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MO95ZA9*K&;L/%-+%L@=04N_1(12(%]HOA7-Z2$<M G+3\D)[$6M<T$S"$P!
M!VQ(*^2V1M!2+QQ##6)?HJT5J3F'\ES#/@=\\60Z&R,D-;L+_-!8^ICZ&.-)
M.K!LZF!7$$%2'C%X=F.%<?%OTEO-]V&&W,4>37SE:!98=>Z3,=5&4X8XR,5\
M'F]:S:@ ,I9MEDV^_G=\&U7N#1/0$A"YL46C)EA,MX&(=]2U+0A4R=1-Z>Q%
MI:5 H&ASB+#T""DS;#;O<MF^.MI:JYIFP1 )N4 EO[$E-^C(6B/4:2U9YB'I
M?L*"X30TLC>!*CGVO.$8DAY2]>%!H^]AJO"OOD?-Q;S?Y<P@*@P_Q*R4%VX%
M^ #P_QTK)L+&,W_@M("Q55@ [*(F-6 '*!@QZ&7;ABK)B,%0OE1!3 (%7)Q^
ME^A9.CS@B*JOM09^V#Z,/!-"Y<4KNP,7VX$LRGPJ5'H=WFBY\!=BXJ&H(M'S
MC#UU(1HD3ZM72X=3PK0%WX)C*H,Q)!7"0BAAD-=!#@!3HJ",^,>3A3%M\<P,
MJXV^.XN5"$1*(LT6WU+J<X*$D,W8X8@(%NXRS*B$3] T3ZINEO,\4=DR*K+H
MJ<D+4DJKBBJJ$P84?'. ,N1G"/IHH(C\/LY>,,I9-1'#0HU!Y2K/(#!5IW]7
MEOVA#HM&#89#!66EAW)V%(5*-8<-VD"M0Y%( T)<SWJ4=1&&S8%J.U-V?7@0
MV[8,*Y]?4B54R"[RHIV(WTC]-7 82:Q/.GP$"_8<GR3E,Q+>(_:.JG)%=$Z\
M/C(&Q6(B-E&\(T?&A04I,>O$QZ$$L!?%A)(/)'$K.1$/8ZF[1EPON@()11'X
ME+;K(1XC_$1_]ZPG[KD_>(,[PR^,;&I$>D?U/%1?U4)?]WATC@$%&,.Q>-$R
M6#IV">;*(_FSW^ ((Q4>PZ4M)W)"51O@X4$=(T0JFH:P1/\9 =GJVT$D;G&*
M 4BY\]O?KRXR9G58IT3$977)^\.HA!<K#T'887LA*I%0[ R/8_D4HQN((*)]
M,BZ:P$<R2A7M5?Z@^A;E?G=!HBS;A7+E4%G/RX:ST2(EA*\:;Q/6%T_J7<,Q
M'&A'=1LXBB-2-O[ #T27R3JYT4X551=&AC0@#%DN-J/5""WGT<J]<&?LA5T2
M=1* PIG2; "T..R]"!E$U2G%C".*2;7@A, R5P$Q2S0^$HRN$7D\H=22SA16
M7*)L6+J=Y2,"1<2:UT/U/;*%F.18=J&A.N".=#1>K$D-\A'[J(55]30(')N0
MWW0Y%E8AQ1Q=W-;.WP,W6B2Q9/%H3(*MME%I*TN!U^O;7=G.H_IXR- 'GU"9
MMXAEO,-I5#K&I2(8+W71"V+S>N6LWOCX4##^5;TN?UD33''#H60!1I(_(65X
M\BL6N2E1U2Z)*%EJNS#]8F_22&FGC/+%.4_2KC$DBS!3A@I7H0[,1SRR5'G1
M*# :R865@+C2;3-P1R"R_!6 AP>S.A\^TTC!1)H:J @01"9E>H:EVBTA:XN;
MEG(RC)GM#2_748:LLAJ&@<Z9;1!C'1"DM"/9NVPWA+%*,X0BC,.#-L<L#6G#
M^9H?HNE=4>\#BE.RB99O@@"F?K&]8#)49O=#&-/:(9#3;W" T0Q&#P4]8 ?X
MZ^M%O787\DPS&M$;#:N+I )]6?8DA!K@&OZ#N=&CKQ?7[T>J;8'O1TIA5V&L
M18J)C:1JB0EQ"Q43&ZO6$E/NH\-)8O&VM!+#"N4YZXB-R67$#R/4(*&S>$$Q
M<;>DNA%TQ$S5T.O 28ZC'ILQ8I^.V&4CN?!MN!1TCAQ(4>= MCH'DDQ//(H9
MIP\Z$X/(TGH245#$#_N%Y2]2>L5&<*K@?+_GJIYK>:'!S+C^(!S"I^Y!H2F5
MTC!Y:=O)1'B\)+>'"0NU+8\:8:A0A-PCW+S*AW9QEE_/%NK[HU%;Y?DR%88D
M4^7R_+:>R6>SYW]2I&?HF&7^]UHY7]A8T74O1!L>S]R?G4_Z^.Q++?KX=Q'<
M"_\W];[__E\YHR'Z\PO7CLDA#MP/R.E278_H(_ARSG-7UEI%E07,Z,E0YQ,(
MPN"5VKZ7L:W9I7[?5KBCTO6P4(?2]WTTG)61SINBX;K?7\1;_C?]HG5&.XAL
ME<M<NR[ES>M1W<[V9Q]1_S]2*UU&7;\!%FP@4'185):$\P#"6'MTMXEJ'LS8
M"B*Q2J;X?."_^[!V>Q#YOM2JUN%> \/HF(VSK;!V0> T3S5"05W)<(?^;8#C
MZ<#H 6,<0Z?75ACM .<!.<2H-2G/:5:K13(U?#%[=W0"9C3Z053?9EM=:4N[
M+/Y=3GEH*J4!'QQ@[#;^DI8"9BY4D84TN'QEO@>XI"QH&JWVB \KIGP2#;ES
MJ$=TI+9#C1\->V=CAA#9QM1:H[X.V\=BPL  3.%TZB9E$$)1'@QZ*CA(-ZE)
MO\V2T%6S2D&B=H=Q5M78V^7#\<GJ(UGG]?+39OS#:#HN>B888A_]+@+PY6<4
MX+!0;+_\BW),7GZ,?G]WPM=[>"?(<,UH*U$+[OC.9=]I^#%Y'D #-O>P=;B%
M\ 7SG%P]'Y$Q@Z 0N'!FY>-&)8945_FGVX_5R/%G[@T+SV83J52Q]-8HT161
M4*S@:5@Y)-T"8/+68U19)G&AJH<PUR:I&4BD/QP.S0P<YASJ_UC)$N%7G<A
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M4$L! A0#%     @ >H&N6JDS]_<K P  [@L  !$              ( !
M &-T<V\M,C R-3 U,30N>'-D4$L! A0#%     @ >H&N6B0NS8S\"@  ?X8
M !4              ( !6@,  &-T<V\M,C R-3 U,31?;&%B+GAM;%!+ 0(4
M Q0    ( 'J!KEHT'/J^6@<  -Q7   5              "  8D.  !C='-O
M+3(P,C4P-3$T7W!R92YX;6Q02P$"% ,4    " !Z@:Y:NB.?%ZD2  #K9
M$@              @ $6%@  =&TR-3$U,30T9#%?.&LN:'1M4$L! A0#%
M  @ >H&N6NR=+L7M/@  Z!T# !8              ( ![R@  '1M,C4Q-3$T
D-&0Q7V5X.3DM,2YH=&U02P4&      4 !0!) 0  $&@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>tm2515144d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ctso-20250514.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
        </entity>
        <period>
            <startDate>2025-05-14</startDate>
            <endDate>2025-05-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-14" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-14" id="Fact000004">0001175151</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-14" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-14" id="Fact000010">2025-05-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-14" id="Fact000011">CYTOSORBENTS CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-14" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-14" id="Fact000013">001-36792</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-14" id="Fact000014">98-0373793</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-14" id="Fact000015">305         College Road East</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-14" id="Fact000016">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-14" id="Fact000017">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-14" id="Fact000018">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-14" id="Fact000019">732</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-14" id="Fact000020">329-8885</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-05-14" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-14" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-14" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-14" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-05-14" id="Fact000025">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-05-14" id="Fact000026">CTSO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-05-14" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-14" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
